Real-time enrollment status for this recurrent endometrial carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:07 PM UTC
| NCT Number | NCT05603910 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Endometrial Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Aaron Wolfson |
| Last Updated on CT.gov | February 24, 2026 (Feb 24, 2026) |
As of July 13, 2026: Clinical trial NCT05603910 is currently recruiting participants. This clinical trial study for recurrent endometrial carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Aaron Wolfson. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05603910 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05603910 was last updated Feb 24, 2026 (February 24, 2026). HelloStudys verifies this status automatically.